This must be the date Novartis is going to close on buying the company for nothing less than the poison pill, right? I bet Berger did this offering just so Novartis would be more enticed to pay $65.00 for a company with an extra $300 million in fresh cash, no?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.